Clinical Trials for BeOne Medicines

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BeOne Medicines

Clinical Trials (6)

NCT06849713
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL
PHASE2Recruiting
40 participants
Started: May 16, 2025 · Completed: Mar 1, 2030
2 conditions2 sponsors2 locations
NCT06637501
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
94 participants
Started: Nov 14, 2024 · Completed: Jun 30, 2030
1 condition1 sponsor38 locations
NCT06568614
An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Oct 12, 2024 · Completed: Dec 30, 2028
1 condition1 sponsor3 locations
NCT05596097
Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission
PHASE2Not yet recruiting
15 participants
Started: Oct 30, 2022 · Completed: Jul 30, 2026
1 condition2 sponsors1 location
NCT05326308
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
N/ARecruiting
705 participants
Started: Apr 26, 2022 · Completed: Aug 31, 2028
4 conditions2 sponsors2 locations
NCT05152147
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
PHASE3Active, not recruiting
920 participants
Started: Dec 2, 2021 · Completed: May 15, 2026
3 conditions3 sponsors226 locations